Life Technologies Sees Bright Future for Quantum Dots in G3 Sequencer

Building on its experience in different technology areas, the company is currently developing the single-molecule platform, which it plans to start testing next year with external collaborators such as the J. Craig Venter Institute.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.